Category: News

Thoughts On Senate Passing Trade-Secrets Bill

Through a nearly unanimous vote, the Senate passed the Defend Trade Secrets Act of 2016 on April 4, creating a civil cause of action in federal court for misappropriation of trade secret.

Cuozzo Speed Technologies, LLC v. Lee

On April 25, the Supreme Court will hear oral arguments in a patent case that has implications for the integrity of the patent system. At issue is the continued viability of the most comprehensive reform of the patent system since 1952, the America Invents Act.

Supreme Court Case on Enhanced Damages

When can a patent owner obtain enhanced damages in a successful suit for patent infringement? What is the relationship between the standard for awarding enhanced damages and awarding attorney’s fees in patent cases? These and other questions were debated before the Supreme Court on February 23, 2016, in a pair of consolidated cases, Halo Electronics v. Pulse Electronics and Stryker Corp. v. Zimmer. The final decision, to be announced in the next few months, will affect patent practice as well as the pace of technology development and litigation.

Goldman Sachs Programmer on Trial for “Stolen Code”

Sergey Aleynikov is a former Goldman Sachs computer programmer who in 2009 was charged in federal court with violating the Economic Espionage Act (EEA) and the National Stolen Property Act (NSPA) after it was found that he had e-mailed himself 8 megabytes of source code four separate times that came… Read More»

Disruptive Technologies and the Struggle for Regulation

Occasionally innovations move so quickly or are so novel that legislative and regulatory bodies can have a hard time keeping up. Recently, this struggle has been exemplified in the Federal Aviation Administration’s dealings with drones, or unmanned aerial systems (UAS), for commercial use. The FAA has authority to regulate and… Read More»

Venture Philanthropy and Drug Development

Historically, disease foundations provide funding for academic research toward treatment or cures. However, a different method of providing support directly to companies, called venture philanthropy, has begun to gain attention. The nonprofit Cystic Fibrosis Foundation began providing funding to a small biotech company to develop drugs for treating the disease… Read More»